Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSanofi india

    Sanofi India

    Jump to

    • Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y

    • Stocks to Watch Today: Coal India, Shanti Gold, Swiggy, PB Fintech, Chalet Hotels, RR Kabel, JSW Energy, Aarti Industries, ITC, Eicher Motors in focus on 1 August

      Stocks to Watch Today, 1 August: Stocks like Coal India, Shanti Gold International, Swiggy, PB Fintech, Chalet Hotels, RR Kabel, JSW Energy, Aarti Industries, ITC, Eicher Motors, and Gujarat Gas will be in focus on August 1.

    • Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India

      'Over 100 million Indians are living with type 2 diabetes and its complexities in India,' said Eric Mansion from Sanofi.

    • Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y

    • Stocks to Watch Today: TCS, Biocon, GAIL, Greaves Cotton, Sun Pharma, Dishman Carbogen Amcis, Coromandel International in focus on 11 April

      Stocks to Watch, 11 Apr: Stocks like TARC, Bharti Hexacom, Infosys, Aurobindo Pharma, Bharat Heavy Electricals, Bank of India, Tata Steel, Sanofi India, Punjab National Bank, Axiscades Technologies, JSW Energy, Eternal, Federal Bank, Bajaj Healthcare, SRF, Samvardhana Motherson International, IIFL Finance, and Northern Arc Capital will be in focus on April 11.

    • Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y

    • Sanofi India shares rise 4% on strong topline and operational show, net profit sharply lower

      Sanofi’s cardiovascular (CV) and central nervous system (CNS) therapies have gained traction, supported by partnerships. Rodolfo Hrosz, Managing Director of Sanofi India said the execution of these partnerships has met expectations, pointing to promising growth potential in coming quarters.

    • Stocks to Watch Today: HCL Tech, Sanofi India, KSB, PB Fintech, Transrail Lighting, Tata Power, Granules India, Kernex in focus on 28 February

      Stocks to Watch, Feb 28: Stocks like Schaeffler India, GE Power India, Coal India, Servotech Renewable Power System, Chemplast Sanmar, Rail Vikas Nigam, Life Insurance Corporation of India, InterGlobe Aviation, SpiceJet, Orient Technologies, Kisan Mouldings, HP Telecom India, and Swasth Foodtech India will be in focus on February 28.

    • Panacea Biotec hits 52-week high after settling patent dispute with Sanofi

      The stock touched its 52-week high of Rs 349.79 per share on the NSE, up 5 percent to hit the highest permissible trading limit on Tuesday.

    • Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y

    • Sanofi India Standalone June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y

    • Sanofi India Standalone March 2024 Net Sales at Rs 732.40 crore, down 0.56% Y-o-Y

    • Sanofi India Q4 results: Net profit down 28% to Rs 136 crore

       Sanofi India Q4: Revenue came in at Rs 732.4 crore, down 0.5 percent from the year-ago quarter

    • French pharma major Sanofi plans first-in-class drug launches in India

      To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy’s, and Emcure Pharma

    • Cipla, Sanofi India shares gain on distribution agreement

      Cipla will be responsible for the distribution of Sanofi India’s six central nervous system products, including Frisium, a leading brand in the anti-epileptic medication category

    • Sanofi, Cipla seal exclusive distribution partnership to expand reach of CNS portfolio in India

      Cipla will utilise its skills and solid network of distributors, institutions, and market outreach programmes to expand access to these treatments for patients, while Sanofi India will continue to own, import, and manufacture its entire range of CNS products across plants in India and abroad

    • Sanofi India inks distribution pact with Emcure, but shares trade flat

      The share touched a 52-week high of Rs 9,370.35 and a 52-week low of Rs 5,329.70 on 23 February, 2024 and 03 May, 2023, respectively.

    • Sanofi India Standalone December 2023 Net Sales at Rs 693.90 crore, up 3.27% Y-o-Y

    • Shares of Sanofi India falter after tepid Q1 results

      According to the company, price revision to products listed in NLEM led to weak revenue growth.

    • Sanofi India Standalone June 2023 Net Sales at Rs 706.10 crore, up 0.97% Y-o-Y

    • Sanofi India gets marketing nod for atopic dermatitis treatment medication

      The company said Dupixent is the first biologic medicine for the treatment of moderate-to-severe atopic dermatitis in adults whose disease is not adequately controlled with topical prescription therapies.

    • Buy Sanofi India; target of Rs 7500: Sharekhan

      Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 7500 in its research report dated May 18, 2023.

    • Vaccine maker Sanofi India to demerge consumer healthcare business

      Upon completion of the proposed demerger, the global parent Sanofi will continue to own a 60.4 percent stake in both entities

    • Hold Sanofi India; target of Rs 6270: ICICI Direct

      ICICI Direct recommended hold rating on Sanofi India with a target price of Rs 6270 in its research report dated February 27, 2023.

    • Sanofi India shares clock biggest intraday gain in 7 months on robust bottomline

      Elara Capital gave a Buy call for the stock as it sees an upside potential of 26%

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347